358 related articles for article (PubMed ID: 18348083)
1. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
2. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
Yamada Y; Ando F; Niino N; Shimokata H
Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
[TBL] [Abstract][Full Text] [Related]
3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
4. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
6. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
7. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.
Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D
Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
9. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
[TBL] [Abstract][Full Text] [Related]
10. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
11. [Study of the impact of candidate genes on bone mineral density in postmenopausal women].
Zhao HY; Liu JM; Ning G; Zhang LZ; Song HD; Chen Y; Jiang L; Dai M; Xu MY; Chen JL
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):803-7. PubMed ID: 16412323
[TBL] [Abstract][Full Text] [Related]
12. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
15. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
Strandberg S; Nordström P; Lorentzon R; Lorentzon M
J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population.
Wynne F; Drummond F; O'Sullivan K; Daly M; Shanahan F; Molloy MG; Quane KA
Calcif Tissue Int; 2002 Jul; 71(1):26-35. PubMed ID: 12073153
[TBL] [Abstract][Full Text] [Related]
18. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
Vidal C; Brincat M; Xuereb Anastasi A
Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
20. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
